Pfizer disclosed a patient death in a marstacimab hemophilia study, triggering a safety review and reassessment of surgical ...

Soleno Therapeutics (NASDAQ:SLNO) advances rare disease research as nasdaq today discussions include clinical-stage ...

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...

The world faces unresolved conflicts, growing climate crises, attacks on aid workers, two famines, and diminishing political will—along with significant aid cuts. Altogether, 2025 has earned a grim ...

Renown Transplant Institute completed its first three kidney transplants in 2025Reno, Nev., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Celebrating the anniversary of the world’s first kidney transplant, the ...

13. LIST OF WINNERS : For the list of winners, mail a self-addressed, stamped envelope to: "2025 NFL Saturday Super 6 Challenge" Winner List, 2100 E. Robinson St., Orlando, FL 32803 (VT Residents may ...

Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) ...

Fiscal 2025 Results Consistent with Preliminary Unaudited Ranges Disclosed November 25, 2025 BNC First Day Program Revenue Increases 25% in 2025; Fall 2025 First Day Complete Enrollment Grows 24% Comp ...

Azimut Exploration Inc. ("Azimut" or the "Company") (TSXV: AZM) (OTCQX: AZMTF) is pleased to announce additional significant exploration progress ...

Here below you have a complete description of its most interesting features and benefits so you can make the most of it. The majority of other information websites display prices of a single source, ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Investing.com -- Agios Pharmaceuticals announced that the U.S. Food and Drug Administration has approved mitapivat for treating anemia in adults with alpha- or beta-thalassemia. The treatment will ...